211 related articles for article (PubMed ID: 10569412)
1. Ototoxic impact of cisplatin in pediatric oncology patients.
Berg AL; Spitzer JB; Garvin JH
Laryngoscope; 1999 Nov; 109(11):1806-14. PubMed ID: 10569412
[TBL] [Abstract][Full Text] [Related]
2. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.
Knight KR; Kraemer DF; Winter C; Neuwelt EA
J Clin Oncol; 2007 Apr; 25(10):1190-5. PubMed ID: 17401008
[TBL] [Abstract][Full Text] [Related]
3. Left-right asymmetry in hearing loss following cisplatin therapy in children--the left ear is slightly but significantly more affected.
Schmidt CM; Knief A; Lagosch AK; Deuster D; am Zehnhoff-Dinnesen A
Ear Hear; 2008 Dec; 29(6):830-7. PubMed ID: 18772725
[TBL] [Abstract][Full Text] [Related]
4. Distortion product otoacoustic emissions test is useful in children undergoing cisplatin treatment.
Toral-Martiñón R; Shkurovich-Bialik P; Collado-Corona MA; Mora-Magaña I; Goldgrub-Listopad S; Shkurovich-Zaslavsky M
Arch Med Res; 2003; 34(3):205-8. PubMed ID: 14567400
[TBL] [Abstract][Full Text] [Related]
5. [Detection of ototoxic effect of cisplatin with otoacoustic emission in testicular cancer patients].
Biró K
Magy Onkol; 2009 Sep; 53(3):279-83. PubMed ID: 19793694
[TBL] [Abstract][Full Text] [Related]
6. [Detection of late ototoxic side effect of cisplatin by distortion otoacoustic emission (DPOAE)].
Biró K; Noszek L; Prekopp P; Nagyiványi K; Géczi L; Gaudi I; Bodrogi I
Magy Onkol; 2006; 50(4):329-35. PubMed ID: 17216007
[TBL] [Abstract][Full Text] [Related]
7. [Monitoring hearing during ototoxic cisplatin therapy].
Kluba J; Kluba U; von Specht H; Mittler U
Padiatr Grenzgeb; 1990; 29(1):19-23. PubMed ID: 2342815
[TBL] [Abstract][Full Text] [Related]
8. [Cisplatin and carboplatin-induced ototoxicity in children: clinical aspects and perspectives for prevention].
Montaguti M; Brandolini C; Ferri GG; Hatzopoulos S; Prete A; Pession A
Acta Otorhinolaryngol Ital; 2002 Feb; 22(1):14-8. PubMed ID: 12236007
[TBL] [Abstract][Full Text] [Related]
9. [Hearing loss caused by high dose carboplatin therapy].
Lautermann J; Adamczyk M; ten Cate WJ; Kloke O
Laryngorhinootologie; 1998 Feb; 77(2):82-4. PubMed ID: 9555700
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of auditory neuropathy/synaptopathy in a population of children with profound hearing loss.
Foerst A; Beutner D; Lang-Roth R; Huttenbrink KB; von Wedel H; Walger M
Int J Pediatr Otorhinolaryngol; 2006 Aug; 70(8):1415-22. PubMed ID: 16574250
[TBL] [Abstract][Full Text] [Related]
11. Auditory steady-state responses to bone conduction stimuli in children with hearing loss.
Swanepoel de W; Ebrahim S; Friedland P; Swanepoel A; Pottas L
Int J Pediatr Otorhinolaryngol; 2008 Dec; 72(12):1861-71. PubMed ID: 18963045
[TBL] [Abstract][Full Text] [Related]
12. Hearing assessment in pre-school children with speech delay.
Psillas G; Psifidis A; Antoniadou-Hitoglou M; Kouloulas A
Auris Nasus Larynx; 2006 Sep; 33(3):259-63. PubMed ID: 16420975
[TBL] [Abstract][Full Text] [Related]
13. The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy.
Abujamra AL; Escosteguy JR; Dall'Igna C; Manica D; Cigana LF; Coradini P; Brunetto A; Gregianin LJ
Pediatr Blood Cancer; 2013 Mar; 60(3):474-8. PubMed ID: 22744939
[TBL] [Abstract][Full Text] [Related]
14. [Ototoxicity of cisplatin in children with malignant diseases].
Hadjilaskari P; Fengler R; Hartmann R; Henze G
Klin Padiatr; 1989; 201(4):316-21. PubMed ID: 2779137
[TBL] [Abstract][Full Text] [Related]
15. cis-platinum ototoxicity in children.
Weatherly RA; Owens JJ; Catlin FI; Mahoney DH
Laryngoscope; 1991 Sep; 101(9):917-24. PubMed ID: 1886439
[TBL] [Abstract][Full Text] [Related]
16. Progressive hearing loss after completion of cisplatin chemotherapy is common and more pronounced in children without spontaneous otoacoustic emissions before chemotherapy.
Weissenstein A; Deuster D; Knief A; Zehnhoff-Dinnesen AA; Schmidt CM
Int J Pediatr Otorhinolaryngol; 2012 Jan; 76(1):131-6. PubMed ID: 22104469
[TBL] [Abstract][Full Text] [Related]
17. Distortion product otoacoustic emissions: an objective technique for the screening of hearing loss in children treated with platin derivatives.
Dhooge I; Dhooge C; Geukens S; De Clerck B; De Vel E; Vinck BM
Int J Audiol; 2006 Jun; 45(6):337-43. PubMed ID: 16777780
[TBL] [Abstract][Full Text] [Related]
18. [Hearing status of Robin sequence patients].
Medard C; François M; Narcy P
Ann Otolaryngol Chir Cervicofac; 1999 Dec; 116(6):317-21. PubMed ID: 10615523
[TBL] [Abstract][Full Text] [Related]
19. Audiologic and vestibular findings in a sample of human immunodeficiency virus type-1-infected Mexican children under highly active antiretroviral therapy.
Palacios GC; Montalvo MS; Fraire MI; Leon E; Alvarez MT; Solorzano F
Int J Pediatr Otorhinolaryngol; 2008 Nov; 72(11):1671-81. PubMed ID: 18814921
[TBL] [Abstract][Full Text] [Related]
20. Auditory neuropathy in children: diagnostic criteria and audiological test results.
Kirkim G; Serbetçioğlu MB; Ceryan K
Kulak Burun Bogaz Ihtis Derg; 2005; 15(1-2):1-8. PubMed ID: 16340284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
